234 related articles for article (PubMed ID: 32499653)
1. Sialylation of immunoglobulin E is a determinant of allergic pathogenicity.
Shade KC; Conroy ME; Washburn N; Kitaoka M; Huynh DJ; Laprise E; Patil SU; Shreffler WG; Anthony RM
Nature; 2020 Jun; 582(7811):265-270. PubMed ID: 32499653
[TBL] [Abstract][Full Text] [Related]
2. Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy.
Suber J; Zhang Y; Ye P; Guo R; Burks AW; Kulis MD; Smith SA; Iweala OI
Front Immunol; 2022; 13():974374. PubMed ID: 36248809
[TBL] [Abstract][Full Text] [Related]
3. A single glycan on IgE is indispensable for initiation of anaphylaxis.
Shade KT; Platzer B; Washburn N; Mani V; Bartsch YC; Conroy M; Pagan JD; Bosques C; Mempel TR; Fiebiger E; Anthony RM
J Exp Med; 2015 Apr; 212(4):457-67. PubMed ID: 25824821
[TBL] [Abstract][Full Text] [Related]
4. Non-Digestible Oligosaccharides Can Suppress Basophil Degranulation in Whole Blood of Peanut-Allergic Patients.
Hayen SM; den Hartog Jager CF; Knulst AC; Knol EF; Garssen J; Willemsen LEM; Otten HG
Front Immunol; 2018; 9():1265. PubMed ID: 29942305
[TBL] [Abstract][Full Text] [Related]
5. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens.
de Leon MP; Drew AC; Glaspole IN; Suphioglu C; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2005 Aug; 35(8):1056-64. PubMed ID: 16120088
[TBL] [Abstract][Full Text] [Related]
7. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
8. RBL cells expressing human Fc epsilon RI are a sensitive tool for exploring functional IgE-allergen interactions: studies with sera from peanut-sensitive patients.
Dibbern DA; Palmer GW; Williams PB; Bock SA; Dreskin SC
J Immunol Methods; 2003 Mar; 274(1-2):37-45. PubMed ID: 12609531
[TBL] [Abstract][Full Text] [Related]
9. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions.
Pennington LF; Gasser P; Brigger D; Guntern P; Eggel A; Jardetzky TS
J Allergy Clin Immunol; 2021 Oct; 148(4):1049-1060. PubMed ID: 33991582
[TBL] [Abstract][Full Text] [Related]
11. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
[TBL] [Abstract][Full Text] [Related]
12. Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses.
Sun J; Arias K; Alvarez D; Fattouh R; Walker T; Goncharova S; Kim B; Waserman S; Reed J; Coyle AJ; Jordana M
J Immunol; 2007 Nov; 179(10):6696-703. PubMed ID: 17982059
[TBL] [Abstract][Full Text] [Related]
13. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
14. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.
Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM
J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573
[TBL] [Abstract][Full Text] [Related]
15. Non-IgE-mediated anaphylaxis.
Cianferoni A
J Allergy Clin Immunol; 2021 Apr; 147(4):1123-1131. PubMed ID: 33832694
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Ara h 2 to peanut-specific, immunoglobulin E-mediated, cell activation.
McDermott RA; Porterfield HS; El Mezayen R; Burks AW; Pons L; Schlichting DG; Solomon B; Redzic JS; Harbeck RJ; Duncan MW; Hansen KC; Dreskin SC
Clin Exp Allergy; 2007 May; 37(5):752-63. PubMed ID: 17456223
[TBL] [Abstract][Full Text] [Related]
17. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A
J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318
[TBL] [Abstract][Full Text] [Related]
18. IgE Glycosylation in Health and Disease.
Shade KT; Conroy ME; Anthony RM
Curr Top Microbiol Immunol; 2019; 423():77-93. PubMed ID: 30820668
[TBL] [Abstract][Full Text] [Related]
19. Peanuts can contribute to anaphylactic shock by activating complement.
Khodoun M; Strait R; Orekov T; Hogan S; Karasuyama H; Herbert DR; Köhl J; Finkelman FD
J Allergy Clin Immunol; 2009 Feb; 123(2):342-51. PubMed ID: 19121857
[TBL] [Abstract][Full Text] [Related]
20. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
Brandström J; Vetander M; Lilja G; Johansson SG; Sundqvist AC; Kalm F; Nilsson C; Nopp A
Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
